Evidence map›Paper›PMID 42428185›Full record

ArticleCureus2026

Robotic Excision and Pathologic Profiling of Nonfunctioning Juxtaglomerular Cell Tumor of the Kidney: First Reported Case From the Indian Subcontinent.

Rohit S Deshpande, Abhinav Voona, Nevitha Athikari Manamal, Akash M Shah, Yuvaraja Thyavihally

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rohit S DeshpandeRobotic Surgery and Uro-Oncology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, IND.
Abhinav VoonaUrology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, IND.
Nevitha Athikari ManamalPathology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, IND.
Akash M ShahRobotic Surgery and Uro-Oncology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, IND.
Yuvaraja ThyavihallyRobotic Surgery and Uro-Oncology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juxtaglomerular cell tumor (JGCT), also known as reninoma, is an exceptionally rare benign renal neoplasm arising from modified smooth muscle cells of the afferent arteriole of the juxtaglomerular apparatus. The tumor classically presents in young patients with secondary hypertension due to autonomous renin secretion, hypokalemia, and hyperaldosteronism.  A 56-year-old asymptomatic female with known hypothyroidism was incidentally detected to have a right renal mass on a routine health check-up. Contrast-enhanced computed tomography (CECT) confirmed a 2.7 × 2.5 cm homogeneously enhancing medullary lesion in the inter and lower polar region of the right kidney with mass effect and calyceal splaying. She underwent robot-assisted right partial nephrectomy. Histopathology confirmed a juxtaglomerular cell tumor, limited to the kidney, with uninvolved margins. Immunohistochemistry showed diffuse positivity for vimentin, smooth muscle actin (SMA), caldesmon, and CD34. This case is atypical in its presentation - an older, asymptomatic, post-menopausal female without the classic triad of hypertension, hypokalemia, and elevated renin levels. Nephron-sparing surgery is the treatment of choice whenever feasible. A high index of suspicion and a characteristic immunohistochemistry (IHC) profile are essential for definitive diagnosis.

Indexed as

immunohistochemistryjuxtaglomerular cell tumornephron-sparing surgeryrobotic partial nephrectomysmall renal mass

Identifiers

PMID42428185
PMCPMC13348948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.